Nausea and vomiting are among the most common side effects from GLP-1 injections, such as semaglutide (Wegovy) and tirzepatide (Mounjaro), for weight management or diabetes control
Results: No glucose infusion was required in lean subjects to sustain euglycemia (glucose clamp) during saline or GLP-1m infusions
A type 2 diabetes subtype responsive to ACCORD intensive glycemia treatment
GLP-1 Receptor expression within the human heart
The diarrhea and dehydration caused by the drug can lead to increased blood viscosity, increasing the risk for the formation of blood clots
Treg cells, without directly infiltrating the brain parenchyma, suppress excessive microglial activation by secreting IL-10, promote oligodendrogenesis by inducing a reparative microglial phenotype through osteopontin secretion, and inhibit pathological astrocyte proliferation via the release of amphiregulin (93)